exendin-4 tirzepatide (TZP) is a 39-amino acid peptide composed of both native Frontiers | Clinical perspectives on
Description
Here is the honest picture

Abstract Purpose of the Review Glucagon-like peptide 1 (GLP-1) receptor agonists (RA) have transformed obesity and type 2 diabetes (T2D) management

Clinical trials demonstrate substantial weight loss with tirzepatide, and many patients report decreased food preoccupation, though individual experiences vary considerably

Effets cardiovasculaires : Augmentation de la frquence cardiaque Hypertension artrielle Effets secondaires divers : Fatigue, perte d'apptit, ractions allergiques (ruptions cutanes, dmangeaisons, difficult respirer)

Most standard doses fall within the easy-to-read range of a U-100 insulin syringe

the human relevance is undetermined
